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Abstract
Motivation: In this study, a method is reported to perform IMRT and VMAT treatment delivery veriﬁcation using 3D volumetric primary beam ﬂuences reconstructed
directly from planned beam parameters and treatment delivery records. The goals of
this paper are to demonstrate that 1) 3D beam ﬂuences can be reconstructed efﬁciently, 2) quality assurance (QA) based on the reconstructed 3D ﬂuences is capable
of detecting additional treatment delivery errors, particularly for VMAT plans,
beyond those identiﬁable by other existing treatment delivery veriﬁcation methods,
and 3) QA results based on 3D ﬂuence calculation (3DFC) are correlated with QA
results based on physical phantom measurements and radiation dose recalculations.
Methods: Using beam parameters extracted from DICOM plan ﬁles and treatment
delivery log ﬁles, 3D volumetric primary ﬂuences are reconstructed by forward-projecting the beam apertures, deﬁned by the MLC leaf positions and modulated by
beam MU values, at all gantry angles using ﬁrst-order ray tracing. Treatment delivery veriﬁcations are performed by comparing 3D ﬂuences reconstructed using beam
parameters in delivery log ﬁles against those reconstructed from treatment plans.
Passing rates are then determined using both voxel intensity differences and a 3D
gamma analysis. QA sensitivity to various sources of errors is deﬁned as the
observed differences in passing rates. Correlations between passing rates obtained
from QA derived from both 3D ﬂuence calculations and physical measurements are
investigated prospectively using 20 clinical treatment plans with artiﬁcially introduced machine delivery errors.
Results: Studies with artiﬁcially introduced errors show that common treatment
delivery problems including gantry angle errors, MU errors, jaw position errors,
collimator rotation errors, and MLC leaf position errors were detectable at less
than normal machine tolerances. The reported 3DFC QA method has greater
sensitivity

than

measurement-based

QA

methods.

Statistical

analysis-based

Spearman’s correlations shows that the 3DFC QA passing rates are signiﬁcantly
correlated with passing rates of physical phantom measurement-based QA
methods.

---------------------------------------------------------------------------------------------------------------------------------------------------------------------This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2016 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.
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Conclusion: Among measurement-less treatment delivery veriﬁcation methods, the
reported 3DFC method is less demanding than those based on full dose re-calculations, and more comprehensive than those that solely checks beam parameters in
treatment log ﬁles. With QA passing rates correlating to measurement-based passing rates, the 3DFC QA results could be useful for complementing the physical
phantom measurements, or verifying treatment deliveries when physical measurements are not available. For the past 4+ years, the reported method has been implemented at authors’ institution 1) as a complementary metric to physical phantom
measurements for pretreatment, patient-speciﬁc QA of IMRT and VMAT plans, and
2) as an important part of the log ﬁle-based automated veriﬁcation of daily patient
treatment deliveries. It has been demonstrated to be useful in catching both treatment plan data transfer errors and treatment delivery problems.
PACS

87.57.Q-, 87.57.cj, 87.57.cp, 87.57.cf, 87.57.cm
KEY WORDS

IMRT, quality assurance, radiation therapy, VMAT

1 | INTRODUCTION

by differences in dose calculation engines and treatment planning
systems (TPS), the accuracy of electron density determined in the

In intensity-modulated radiotherapy (IMRT)1 and volumetric-modu-

daily patient localization cone-beam CT images, and other factors.

lated arc therapy (VMAT),2 radiation is delivered in many individual

Traditionally in IMRT QA, veriﬁcation of delivered 2D ﬂuence

beam apertures of varying intensities to achieve highly conformal dose

maps for individual beams has been widely used.8 Two-dimensional

distributions to the planning target volume (PTV), that minimize dose

beam ﬂuence can be directly measured with various dosimeters

3

to nearby health tissues. During delivery, mechanical parameters (e.g.,

including diode or ion chamber arrays, e.g., MapCheck (Sun Nuclear,

MU, dose rate, gantry angle, collimator angle, jaw position and MLC

Melbourne, FL, USA) or MatriXX (IBA, Bartlett, TN, USA), or even

leaf positions) are synchronized to planned values, speciﬁed by control

with onboard electronic portal imaging devices (EPID).4,24,25 Beam

points (CP).4 Given the complexity of these treatments, quality assur-

2D ﬂuence can also be digitally and proximately reconstructed from

ance (QA) for treatment delivery is essential in detecting various types

treatment plan parameters or LINAC machine log ﬁles by integrating

of delivery failures in order to ensure the accuracy of a patient’s

across a beam aperture multiplied by the per-segment beam

dosimetry and safety. IMRT/VMAT QA can be performed using point

MU.10,26–28 At the authors’ institution, 2D beam ﬂuences digitally

dose and planar dose measurements obtained via physical phantoms,

reconstructed from the DICOM plans and treatment delivery log ﬁles

2D beam ﬂuences, and dose recalculations based on machine delivery

have enabled detection of many errors for IMRT plans, including

log ﬁles.4–6 In comparison to conventional measurement-based QA,

human operating mistakes (resulting in wrong plans, wrong beams,

QA using log ﬁles offers various advantages including sampling higher

or wrong beam parameters), ﬂawed and suboptimal treatment plans

spatial and temporal resolutions, not requiring measurement devices

(containing undeliverable or incorrect machine parameters), data

or phantoms, providing QA for fractional deliveries to patients, and

transfer problems (resulting from unintended parameter changes),

being readily automated.5,6 Performing IMRT QA using log ﬁles has

and other minor false positive errors.11 However, for the case of

been claimed to be more effective and efﬁcient than, and complemen-

VMAT QA, such 2D beam ﬂuence veriﬁcation per beam angle may

tary to, physical dose measurement-based QA.7–12 A major, ongoing

not be appropriate because instantaneous beam aperture errors for

debate in the medical physics community is whether IMRT QA using

VMAT deliveries were signiﬁcant (up to 15%) for highly modulated

log ﬁles can replace conventional measurement-based methods.5

plans even though MLC leaves were well-within tolerances.29 A

Numerous reports on using log ﬁles for IMRT/VMAT QA have

composite 2D ﬂuence for a VMAT beam at a ﬁxed gantry angle

been presented in literature.13–18 Logged beam parameters can be

could be computed,30 but error detection using such ﬂuence is sub-

compared to planned values based on a relatively simple value-to-

optimal due to the ignored gantry rotation. We therefore were moti-

value comparison. Dose recalculations that incorporate parameters

vated to develop an alternative 3D ﬂuence calculation QA method,

recorded in log ﬁles can verify the accuracy of delivered dose. Com-

i.e., 3DFC, that (1) could be more sensitive to detect certain delivery

putation time has been signiﬁcantly reduced with GPU accelera-

machine errors (such as gantry rotation errors), (2) could provide

tion;19–23 however, comparing dose distributions can be complicated

enhanced visualization of beam delivery discrepancies respective to
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the tumor target geometry, and (3) could infer correlations between

~
r with the origin deﬁned at the beam isocenter, the 3D ﬂuence intensity

random treatment delivery discrepancies to dose discrepancies.

Iðr~Þ is calculated, using the beam parameters in the machine log ﬁles, as:

In this study, a simple and efﬁcient QA method based on 3D ﬂu-

Z

ence calculation is reported. This method enables rapid calculation of

Iðr~Þ ¼

3D ﬂuences using beam parameters from machine log ﬁles and
DICOM plan ﬁles. Our goal is not to replace traditional physical
phantom measurement-based QA or a full-scale dose calculation, but
rather to present a simpler, complimentary solution for detecting
potential delivery machine parameters errors and plan parameter
transfer errors with improved 3D visualization. The reported 3DFC
QA method mainly focuses on checking delivery errors of machine
parameters — instead of scrutinizing TPS commissioning errors —
while potentially improving error sensitivities comparing to the traditional QA methods. Toward this goal, we examine correlations
between the resultant passing rates from our reported 3DFC QA
and conventional measurement-based QA in detail.

SAD2
_
Fðr~0 ðtÞÞ  Mðr~0 ðtÞÞ  DðtÞ
dt

jr~ ~ðtÞj
s

(1)

where t is the delivery time, F is the 2D beam intensity proﬁle in air,
D_ is the dose rate in MU/s, SAD is the source-to-axis distance, ~ðtÞ
s is
the source position, and M is the beam aperture mask with M = 1 if
~
r 0 is inside the beam aperture or M = 0 otherwise. Iðr~Þ represents
the total MU delivered to the point ~
r by the cumulative beam aperture the entire beam delivery. It is important to note that beam
attenuation and scattering are not considered as opposed to the dose
calculation in this simple approximation. The computed 3D ﬂuence is
essentially the dose in air. X-ray generated is approximated from the
single radiation source at the X-ray target, and the secondary effective source is not considered. As the mask is not binary in reality, but
a function of the aperture size, the ﬂuence for smaller apertures is

2 | MATERIALS AND METHODS

reduced due to the shadowing of the distributed secondary source
by the MLC. Therefore, we note that an approximation to the real

2.1 | Data

mask counterpart is applied in this calculation.

To calculate and verify the 3D ﬂuence volume, both the planned
beam parameters from DICOM plans and the reported beam param-

r projected on the beam portal at 100 cm SAD
~
r 0 is the point ~
and couch, gantry and collimator are all at 0°:
~
r 0 ðu; wÞ ¼ Rcol ðhÞP½Rg ðbÞRcouch ðaÞr~

eters from the beam delivery log ﬁles are used. Beam parameters
are deﬁned similarly in the DICOM plans and machine log ﬁles. In
DICOM plans, beam parameters are deﬁned in control points, which
are checkpoints for the treatment machines to synchronize beam
parameters. For example, a control point deﬁnes the gantry, collimator, jaw, and MLC leaf positions, as well as the accumulated beam
monitor units (MU) up to this control point. In machine log ﬁles,

(2)

where Rcouch, Rg, and Rcol are the couch, gantry, and collimator rotation matrices, respectively, and a, b, and h are the beam couch, gantry, and collimator angles, respectively. P is a 3D-to-2D projection
operator that projects a 3D coordinate ~ðx;
r y; zÞ to a point ~
r 0 ðu; wÞ
within the beam portal according to:
2 xSAD 3

each record stores the same beam and dosimetric parameters mea-

6
~
r 0 ðu; wÞ ¼ P½r~ðx; y; zÞ ¼ 6
4

sured at ﬁxed intervals throughout delivery. The currently supported
machine log ﬁles are pre-TrueBeam dynamic MLC log ﬁles (dynalog)

yþSAD

7
7
5

(3)

zSAD
yþSAD

and TrueBeam trajectory log ﬁles, both of which are acquired on
Varian linear accelerators. Records are generated every 50 and 20

where u is oriented along the direction of the X-jaws (or MLC

milliseconds for pre-TrueBeam and TrueBeam machines, respec-

motion), and w is given along the direction of the Y-jaws.

tively. TrueBeam trajectory logs also give absolute beam MUs and

The beam aperture mask M is directly calculated using the jaw and

31

dose rate, while dynalog ﬁles only give relative beam MU values.

MLC leaf position data. For the projected point ~
r 0 on the beam portal at

To be concise, only the TrueBeam trajectory log ﬁles and VMAT

(u, w), the corresponding leaf pair number can be calculated using w.

plans will be discussed in the following sections.

The calculation is different for different machine conﬁgurations. For a
Varian Millennium 120 MLC module that has 60 MLC leaf pairs, the

2.2 | 3D ﬂuence calculation (3DFC)

leaf widths are 1 cm for the ﬁrst 10 and last 10 leaves, and 0.5 cm for
the middle 40 leaves. Leaf pair number Lnum is calculated from w as:
 


w þ 20Þ
þ1
Lnum ¼ f int
0:5

Two-dimensional beam ﬂuence can be digitally computed based from
machine log ﬁles by integrating the per-segment beam aperture multi10

plied by the per-segment beam MU.

(4)

In contrast, the 3D volumetric

ﬂuence is calculated by forward-projecting beam apertures, modulated
by beam monitor units (MU), at all beam angles. In this paper, 2D and
3D ﬂuence calculation methods are referred to as 2DFC and 3DFC,
respectively, and IMRT and VMAT delivery QA using 2DFC and 3DFC
methods are referred to as 2DFC QA and 3DFC QA, respectively.
Consider a point ~
r 2 X, where Ω is the target 3D ﬂuence volume
around the beam isocenter. x, y and z represent coordinates of the point

Where
8
< intððt  1Þ=2Þ þ 1
fðtÞ ¼
t  10
:
intððt  61Þ=2Þ þ 51

t 2 ½1; 20
t 2 ½21; 60
t 2 ½61; 80

(5)

where “int” denotes the integer conversion operation. The point ~
r is
considered to be in the beam aperture if u is between the two leaf
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positions for the relevant leaf pair Lnum and within the beam opening

1. Obtaining the treatment plan and the machine delivery logs.

of the X and Y jaws.

2. Calculating the planned and delivered 3D ﬂuences from the
DICOM plan delivery logs using the 3D ﬂuence calculation

For a DICOM plan, the 3D ﬂuence is calculated similarly as:
Iðr~Þ ¼


XN1 
SAD2
0
0
Fðr
~
ðtÞÞ

M
ðr
~
ðtÞÞ

DMU

k
k
k¼1
jr~ ~ðtÞj
s

method.
(6)

3. Performing an intensity difference test (3%) and gamma analysis
(3%, 3 mm) between the planned and delivered ﬂuence values32–35

where k is the control point index and DMUk is the beam MU allo-

and computing the failing rates of both criteria, respectively.

cated between control points k and k+1. The rotation angles used in

4. Generating QA reports for physicists’ analysis and approval.

the calculation of ~
r 0 are the averaged values between points k and

5. Intervening based on failing rates (according to the discretion of

k + 1. Likewise, the planned source position ~
s is averaged between

a physicist).

points k and k + 1 as:
A 3% intensity difference and 3%, 3 mm gamma criterion32–35

~
S k þ 1Þ=2
S ¼ ðS~k þ ~

(7)

are chosen for deﬁning passing rates based on 3DFC comparisons.
In the 3% ﬂuence difference test, each voxel in the planned ﬂuence
map is considered to have passed if the ﬂuence difference between

2.3 | Implementation details

planned and delivered values on the voxel is less than 3% of the

The number of control points in VMAT plans is usually far less than

maximal intensity value. Voxels with intensity values smaller than

the number of records in the machine logs. A single 360° arc with a

10% of the maximal value are excluded from analysis. The failing

total of 91 control points (4° per control point) within its associated

rates of both tests summarize the total number of voxels that fail

plan will be delivered in 2 min. Over this duration over 5000 log

the corresponding criterion out of the total number of voxels in the

records will be generated. With an angular sampling frequency of 4°

ﬂuence map. The chosen parameters for the criteria (3% for ﬂuence

per beam in the plan, the reconstructed 3D ﬂuence volume will have

difference and 3%, 3 mm in the gamma analysis) are selected empiri-

apparent alias; however, the delivery machine linearly interpolates

cally in order to avoid excessive false positives while preserving suf-

the beam parameters between control points in order to smooth the

ﬁcient sensitivity to catch major delivery errors.

expected delivered 3D ﬂuence. To calculate the 3D ﬂuence with

Interventions of medical physicists are decided according to the

high accuracy, the control points in the DICOM plans thus need to

estimated failing rates of the two criteria. For instance, for a lung cancer

be up-sampled accordingly.17 It was empirically determined that 1°

patient with up to 2 mm in simulated random MLC errors, the failing

per control point sufﬁciently reduces alias artifacts.

rate of the 3% ﬂuence difference test was calculated to be 4.8%, and

On the other hand, Varian TrueBeam machines create delivery

the failing rate in gamma analysis (3%, 3mm) was 4.1%. For a heart

records every 20 ms with an equivalent angular resolution of 0.048°.

patient with up to 1° random gantry angle errors, the failing rate of the

Because such high angular resolution is not necessary for detecting

ﬂuence difference test was calculated to be 2.4%, and the failing rate in

gross delivery errors, machine logs are down-sampled by a factor of

gamma analysis was 0.8%. While the threshold values for the action

16 to improve computation speed. To combine multiple records into

levels should be determined with further clinical measurements and

1 segment, the MLC leaf positions and gantry angles are averaged

judgments, which could be treatment site dependent, the general

and the beams MUs are summed.

threshold used in the authors’ clinic is 5% failing rate on 3%, 3 mm

The reconstruction volumes are automatically determined using
the maximal jaw opening from the treatment plan (plus a 1 cm margin)

gamma analysis. If the failing rate of gamma analysis is greater than 5%,
medical physicists should initiate further investigation.

given that the jaw positions are not changing during VMAT delivery. A
voxel size of 3 9 3 9 3 mm3 and 1 degree angular resolution are used

2.5 | Testing with simulated delivery errors

in this study in order to provide adequate spatial resolution for error
detection with high ﬁdelity and reasonable computation time.

In order to evaluate the capabilities of the 3DFC QA to detect delivery problems, we simulate ﬁve types of important machine parame-

2.4 | 3DFC QA for treatment delivery veriﬁcation

ter errors by modifying the treatment plans (easier to modify than
log ﬁles) and comparing the detection results with both 2DFC QA

Figure 1 presents the general workﬂow of VMAT and IMRT 3DFC

methods and conventional measurement-based QA using ArcCHECK

QA, which can be described in details as follows:

(Sun Nuclear Corp, Melbourne, FL, USA). We use the original

T A B L E 1 Normal tolerances and statistical distributions for various sources of errors of the Varian LINAC machines installed in our clinic.
Errors

Gantry

MU

Jaw

Collimator

MLC

Tolerance

1°

1 MU

1 mm

1°

2 mm

Distribution

Uniformly

Uniformly

Uniformly

Uniformly

Gaussian
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Determining
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intervention

The general workﬂow of the VMAT delivery QA.

unmodiﬁed treatment plan to deliver the VMAT beams such that the

The tolerances of beam delivery parameters listed in Table 1 are

machine log ﬁle is recorded from the original plan delivery. Assuming

chosen based on the AAPM Task Group 142 report.36 Furthermore,

the modiﬁed plan is the correct plan, errors within the ﬂuence vol-

the statistical distributions of these types of errors are chosen based

ume will be identiﬁed between the delivery log (from the original

on both the uncertainties of our machines and study reported in

unmodiﬁed plan) and modiﬁed plan (with simulated errors). Testing

Ref.18 Our goal is to test if the 3DFC is useful to detect errors that

of the simulated delivery errors includes two steps:

are otherwise undetectable by value-to-value comparisons of beam

1. Simulation of gantry rotation errors, MU errors, jaw positions

parameters, and to also investigate our method’s performance in

errors, collimator rotation errors, and MLC leaf errors by adding

identifying errors beyond normal tolerances. For each VMAT plan,

random values to the corresponding planned quantities per con-

the types of errors listed above are added one-by-one to the origi-

trol point. These random artiﬁcial errors are speciﬁed according

nal plan. A total of 10 error-introduced plans are thus created with

to their corresponding statistical distributions and range well

ﬁve incorporating errors within tolerance and ﬁve simulating errors

within the corresponding error tolerances for the associated

out of tolerance. The calculated ﬂuences of all plans will then be
compared with the delivery log ﬁle recorded from the original,

parameters (as enumerated in Table 1).
2. Simulation of the errors enumerated above beyond their toler-

unmodiﬁed plan delivery. The passing rates of the 3% intensity dif-

ances, including adding random values between 1° and 2° per

ference test and 3%, 3 mm gamma analysis are used to evaluate the

control point to both the planned gantry rotation angles and col-

detection performance (sensitivity) of the 3DFC QA for each type

limator rotation angles, adding random values between 1 and

of delivery error. Then, the QA results will be compared with the

2 MU per control point to planned MU values, adding random

performance of the 2DFC QA (with the composite 2D ﬂuence being

values between 1 mm and 2 mm to planned jaw positions, and

computed by ﬁxing the gantry angle at 0°), and with the perfor-

shifting random values between 2 mm and 3 mm to either direc-

mance of the conventional measurement-based QA using Arc-

tion of the MLC leaf positions.

CHECK.

errors
MU

Calculated
3D fluence

Plan’

Jaw

Diff

Plan

MLC
errors

Passing rates

Gamma
3D dose
calculated

Plan’

Passing rates
Diff
CORRELATION

Gantry

Plan

Collimator

Gamma
2D dose
measured

Plan’

Passing rates
Diff

errors
Plan

(I) Add Simulated
errors

FIG. 2.

(II) Perform
calculations and
measurements

Gamma

(III) Perform two
criteria of analysis

(IV) Conduct
correlation study

The diagram of the correlation study design between the 3DFC QA and the measurement-based QA.
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(Pearson’s correlation coefﬁcient) and q-value (Spearman’s correla-

2.6 | Correlation study design

tion coefﬁcients) are calculated to measure the extent to which two

In order to evaluate the capabilities of the 3DFC QA to detect dose

variables (e.g., PU;Iðr~Þ and PDC;Iðr~Þ ) tend to change together, including

delivery errors, we quantitatively study the correlation between pass-

both the strength and the direction of the correlation.

ing rates derived from ﬂuence maps and those observed on dose
measurements. Figure 2 schematically illustrates our correlation study
design. Adding the same types of simulated errors to the DICOM
plan (presented in Section 2.5), within their corresponding error tolerances, we calculate 3D ﬂuences, calculate 3D doses within the Pinna-

3 | RESULTS
3.1 | Clinical results

cle TPS (Phillips, Pinnacle), and measure 2D composite doses using

This reported 3DFC QA method has also been applied to QA at

ArcCHECK, for both the original and modiﬁed plans. For each set of

the authors’ institution for IMRT and VMAT treatments for the

calculated ﬂuences, calculated doses, and measured doses, we per-

past 4 + yr. For pre-treatment patient-speciﬁc QA prior to 2014, a

form both an intensity difference test and gamma analysis test in

combination of ion chamber measurements (two points in a cus-

order to evaluate the differences between the original plan and the

tomized cubic solid water phantom), MapCheck QA (per beam at a

error-introduced plans. Finally, a correlation study is conducted on

ﬁxed gantry angle of 0°), and ﬂuence QA (using the log ﬁles

the resultant passing rates, between the ﬂuence and the calculated

acquired in delivery for ion chamber measurements) were applied.

dose, and between the ﬂuence and the measured dose.

Since 2014, a combination of MatriXX QA (planar composite dose

The notation shown in Fig. 2 can be summarized as follows: Φ

measurement of all beams in the coronal plan at isocenter, mea-

denotes ﬂuence, D denotes dose, and P denotes passing rate. The

sured in the standard MatriXX iso-cube water phantom) and ﬂu-

subscript c represents quantities derived from calculation, while the

ence QA (log ﬁles acquired in the MatriXX QA delivery) have been

subscript m represents quantities obtained from measurement. The

used, with the MatriXX QA replacing both ion chamber and per-

0

indicates an error-introduced plan (with the quantities

beam MapCheck measurements. 2DFC QA, which was developed

pertaining to the original plan not including a superscript). PIðr~Þ

prior to the clinical implementation of VMAT, is applied to all

describes the passing rates of the intensity difference test and Pc

IMRT plans. 3DFC QA, which was developed particularly for VMAT

superscript

describes the passing rates of gamma analysis.

delivery veriﬁcation, is applied to VMAT beams. 3DFC QA is cur-

In our correlation study, dose was inferred from both dose calcu-

rently not applied to IMRT plans, not because of technical limita-

lation within the TPS and measurement with ArcCHECK. Calculated

tions but rather for the sake of continuity in our institution’s

dose from the TPS provides 3D dose volumes thus allowing for QA

patient-speciﬁc plan QA paradigm. 2D and 3D ﬂuence-based QA

in 3D, while the measurement-based QA could only be in 2D and is

are implemented together with beam parameter checks in a fully

relatively sensitive to setup errors. After delivery, the measured 2D

automated treatment delivery veriﬁcation program that is scheduled

dose volumes, denoted by Dm and D0m , respectively, are exported

to run every morning to automatically check all treatment deliver-

from the ArcCHECK software for evaluations. The measured doses

ies of the previous day and to alert physicists of any treatment

D0m

delivery issues.

from each error-introduced plan are compared with the planned

calculated dose from TPS (Pinnacle), i.e., Dc.

From 2014 to date, 139 VMAT treatments were veriﬁed using

For the passing rate results, we evaluate differences between: (1)

the reported 3DFC QA method (130 lung cancer patients, 5 heart

calculated 3D ﬂuences Φc and U0c ; (2) calculated 3D planned doses

cancer patients, 3 brain cancer patients, and 1 spine patient). Screen-

Dc and

D0c ;

and (3) measured doses in phantom

D0m

and calculated

doses Dc. 2% and 2%, 2 mm criteria are used in the intensity differ-

shots of this QA software and associated QA reports are illustrated
in (Fig. 3) for one lung patient treated in 2015.

ence tests and gamma analysis for evaluating differences in (1) and

The reported 3DFC QA method was implemented in MATLAB

(2), while 3% and 3%, 3 mm are chosen for evaluating differences in

2012a (Mathworks, Natick, MA, USA). The computational accuracy

(3). The 2% and 2%, 2 mm criteria for (1) and (2) were selected

and speed were tested for different choices of parameters. Voxel

empirically (similarly to the criteria choice for (3), as discussed previ-

sizes and angular resolutions of 3 9 3 9 3 cm3 and 1° were ulti-

ously). Furthermore, for (1) and (2), machine systemic errors, e.g.,

mately chosen for 3D ﬂuence calculations of both treatment plans

setup errors, are not included. Therefore, tighter constraints with

and log records in order to obtain satisfactory spatial resolution and

2%, rather than the 3% difference test and 3%, 3 mm gamma analy-

computation speed. Computation time ranges between 10 and

sis are applied in the ﬁrst two cases (1) and (2).

30 seconds per patient, with the speed ultimately depending on the

Finally, we obtain three groups of resultant passing rates with

number of VMAT beams and the size of the treatment target.

each group consisting of two test results from both evaluation methods, denoted by PU;Iðr~Þ and PΦ,c, PDC;Iðr~Þ and PDC,c, and PDm;Iðr~Þ and
PDC,c. Five passing rates for each plan from ﬁve types of errors are

3.2 | Lung plan

obtained for these three result groups. Both Pearson’s and Spear-

As lung patients are the most common VMAT-treated patients in

man’s correlation coefﬁcients are used to investigate the relation-

our clinic, we present one example of the delivery QA results

ships between groups of passing rates. In particular, r-values

including both the 3D and 2D ﬂuences, using a four-arc right lung
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2D

F I G . 3 . Results of 3D and 2D ﬂuences from a four-arc lung VMAT plan. Top row is from the DICOM plan. Middle row is from the log ﬁle.
Bottom row is obtained by calculating the corresponding ﬂuence differences. The PTV contours in the respective 3D orthogonal views are
overlaid on the 3D ﬂuences.

VMAT plan with a total of 4328 MU. Figure 3 shows both the cal-

(3-arc) VMAT plans were tested for simulated delivery errors. Results

culated 3D and 2D ﬂuences integrated over the four arcs on the

of averaged (mean value) failing rates for the 3% intensity ﬂuence

ﬁrst two rows, including results obtained from both the DICOM

difference test and 3%, 3 mm gamma analysis, denoted by FIðr~Þ;3%

plan and the log ﬁle, respectively. The corresponding calculated ﬂu-

and Fc,3%,3mm respectively, are presented in (Table 2). For instance,

ence map differences are shown on the third row. The 3D ﬂuence vol-

using the 3DFC method, random gantry angle errors up to 1° could

umes with PTV contours drawn are illustrated in axial, coronal, and

cause mean values of 7.4% and 6.2% of voxels to fail the 3% inten-

sagittal views in the ﬁrst three columns, respectively, while the 2D ﬂu-

sity difference test and 3%, 3 mm gamma analysis, respectively. In

ence (computed by forcing gantry angle = 0) is illustrated in the fourth

contrast, these simulated gantry angle errors were never detected by

column. Gantry angle, collimator, jaw, and MLC positions were all within

2D ﬂuence calculations because gantry angles are not used. Based

allowed clinical tolerances during actual delivery. 3D ﬂuence errors are

on these results shown in Table 2, we may therefore conclude that

1.3  1.1 MU and the maximal ﬂuence error is 10.1 MU (0% failing

the 3DFC QA method is more sensitive in detecting gantry angle

rates for both criteria are found). As can be seen, there are only minimal

errors, MU errors, jaw position errors, and collimator rotation errors

ﬂuence differences between the plan and delivery logs. More impor-

than 2D ﬂuence method.

tantly, 3D ﬂuence maps provide a signiﬁcantly improved visualization in

As also summarized in Table 2, we tested both algorithms upon

multiple orthogonal views on the PTV than the 2D map which cannot

adding simulated 1-2 mm random MLC errors. We only adjusted the

be associated with the PTV 3D shape.

position of leaves that actually contribute to ﬂuence during delivery.
As one can see, both 3D and 2D methods are very sensitive to MLC

3.3 | Simulated delivery error results and analysis

position errors. However, the results suggest that the 3DFC QA
method is less sensitive to MLC positional errors than the 2D

As described in Section 2.5, we ﬁrst simulated different types of

method. This might be due to that MLC positional errors only affect

machine errors per control point within normal machine tolerances.

the beam ﬂuence at the edges but not inside of beam portals. Arc-

A total number of 10 patients with ﬁve lung (4-arc) and ﬁve heart

CHECK measurements were performed on these unmodiﬁed VMAT
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T A B L E 2 QA results with simulated delivery errors.
3D Fluence
Simulated errors

2D Fluence
Fc,3%,3mm

FIðr~Þ;3%

2D Measurement
Fc,3%,3mm

FIðr~Þ;3%

FIðr~Þ;3%

Fc,3%,3mm

Errors within machine tolerance
Gantry

7.4%

6.2%

0%

0%

2.3%

1.4%

MU

1.2%

0.5%

0%

0%

0.7%

0%

Jaw

2.7%

1.6%

0.2%

0%

2.5%

0.2%

Collimator

1.6%

0.6%

0.3%

0%

0%

0%

14.3%

6.2%

21.1%

11.0%

13.5%

MLC

5.9%

Errors outside machine tolerance
Gantry

14.1%

10.3%

3.3%

2.7%

11.5%

4.6%

MU

51.5%

37.7%

43.3%

24.2%

47.1%

36.9%

Jaw

11.6%

4.2%

4.8%

2.3%

5.2%

2.6%

Collimator

12.5%

7.3%

4.1%

9.3%

10.4%

3.5%

MLC

26.3%

9.3%

38.9%

24.7%

22.1%

5.9%

(b)

FI(r),3% = 19.5%

FI(r),3% = 42.5%

(d)

FI(r),3% = 38.7%
←

←
←

(c)

FI(r),3% = 8.7%

←

(a)

F I G . 4 . The axial views of ﬂuence differences generating by simulated errors: (a) with ﬁxed 1° gantry angle errors; (b) with ﬁxed 2 mm
shifting MLC leaf position errors; (c) 90% of the plan is interrupted during delivery; and (d) an incorrect version of the plan is delivered.

test plans. For each plan, the measured dose will be compared with

Furthermore, simulated errors outside their corresponding normal

10 calculated dose ﬁles from error-introduced plans (see Sec-

tolerances are tested. Signiﬁcantly greater errors are found in this

tion 2.5). Results presented in (Table 2) show that 3DFC QA is more

case which demonstrates both the conclusion on 3DFC method

sensitive to these simulated machine errors than the conventional

achieving better sensitivity than the 2DFC. Two examples of the cal-

measurement-based QA.

culated 3D ﬂuence differences in axial views are illustrated in
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F I G . 5 . Correlations between the simulated errors and the 3% ﬂuence differences test failing rates for various types of errors using both
3DFC QA in solid lines and 2D ﬂuence QA in dashed lines.
(Fig. 4), where (a) is generated using ﬁxed 1° gantry angle error in
one lung plan, and (b) is generated with ﬁxed 2 mm MLC position

T A B L E 4 Results of correlation coefﬁcients between PΦ and PDm
from all the error types.

errors in the same lung plan. These artiﬁcial errors can be visually

Coefﬁcients

seen in the 3D ﬂuence difference map, which also suggest the feasi-

PU;Iðr~Þ and PDm;Iðr~Þ (3% intensity difference)

bility of our method.

Pearson (r)

0.4121

0.6514

0.5248

0.8554

0.4336

Spearman (q)

0.9701

0.8997

0.9015

0.9810

0.7853

Spearman (p)

0.0232

0.0399

0.0425

0.0315

0.0652

Figure 4 also illustrates two 3D ﬂuence difference maps generated by simulating two common clinical events: interruptive delivery with 10% of the control points left out during treatment, and
delivering the wrong version of the plan (of another lung patient
used).
In order to better understand the relationship between the delivery errors and the performance of the 3DFC QA method, different

Gantry

MU

Jaw

Collimator

MLC

PΦ,c and PDm,c (3%, 3mm Gamma analysis)
Pearson (r)

0.5771

0.5397

0.6541

0.7981

0.5026

Spearman (q)

0.8653

0.9012

0.9520

0.9805

0.7916

Spearman (p)

0.04196

0.0356

0.0492

0.0157

0.0694

values of artiﬁcial errors for each error type are added into each
control point and the corresponding average (mean value) failing
rates of the 3D ﬂuence difference test (3%) are obtained for these
10 VMAT plans. Figure 5 shows plots of the correlations between
the normalized simulated errors and the failing rates both in percentages for all the error types examined in this paper, while results of
the reported 3DFC QA (in solid lines) are compared with those of
the 2D ﬂuence-based QA (in dashed lines). The generated errors are

T A B L E 3 Results of correlation coefﬁcients between PΦ and PDc
from all the error types.
Coefﬁcients

Gantry

MU

Jaw

Collimator

MLC

normalized to the corresponding tolerance in percentage, for
instance, gantry angle errors are scaled to 100% at 1°. As can be
seen, failing rates start to climb much more quickly when the errors
lie outside their normal machine tolerances. It again demonstrates
the conclusion from Table 2 that 3DFC algorithm is more sensitive
to MU, jaw position, and collimator rotation errors than 2DFC, while
2DFC cannot catch gantry rotation errors.

3.4 | Correlation study results on ﬂuence vs. dose
and analysis
In the correlation study, 10 IMRT plans and 10 VMAT plans with

PU;Iðr~Þ and PDc;Iðr~Þ (2% intensity difference)

ﬁve different types of errors were used. Table 3 presents the com-

Pearson (r)

0.5631

0.5489

0.7025

0.8575

0.5297

Spearman (q)

0.9267

0.9183

0.9226

0.9515

0.6754

puted correlations between PU;Iðr~Þ and PDC;Iðr~Þ , and between PΦ,c and

0.0305

PDC,c. Table 4 presents the computed correlation between PU;Iðr~Þ and

Spearman (p)

0.0427

0.0242

0.0475

0

PDm;Iðr~Þ , and between PΦ,c and PDm,c. In both tables, the Spearman’s

PΦ,c and PDc,c (2%, 2mm Gamma analysis)
Pearson (r)

0.6125

0.5987

0.7871

0.8824

0.5011

Spearman (q)

0.9334

0.9423

0.9498

0.9817

0.7042

Spearman (p)

0.0375

0.0197

0.0420

0

0.0421

correlation coefﬁcient q-value is signiﬁcantly closer to +1 than the
Pearson’s correlation coefﬁcient r-value. The p-values for all errors
types are smaller than the signiﬁcance level 5%, which suggest the
statistically signiﬁcant correlation. These results show that the
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resultant passing rates indicated by 3DFC are correlated with the

3DFC is also not designed to replace a full dose calculation, but as

passing rates speciﬁed by dose mapping, obtained from either calcu-

an alternative approach as a delivery QA with enhanced visualization

lation or measurement.

and error sensitivity, focusing directly on checking machine parameters. Comparing to full 3D dose calculation methods, 3DFC ignores
many important physical effects including phantom scattering and

4 | DISCUSSION

attenuation. However, 3DFC is simpler and could be potentially much
faster. The current computation speed, 3 to 20 seconds per VMAT

3DFC QA is useful to detect relatively common treatment delivery

beam, accomplished with MATLAB programs could also be signiﬁ-

imperfections (e.g., imperfect deliveries due to the end effect for

cantly improved when 3DFC is reimplemented in C/C++ or GPU pro-

highly modulated IMRT beams that deliver low MUs, and treatment

grams. It might be worth to note that the computation speed of

delivery interruptions). Although overall treatment delivery accuracy

3DFC is sufﬁcient for clinical use without GPU acceleration. This

has been signiﬁcantly improved by newer LINAC machines, e.g., Var-

allows the reported QA method to be more clinically deployable with-

ian’s TrueBeam, the reported 3DFC QA can serve as an additional

out the need of relatively expensive GPU hardware. As shown in (Sec-

safeguard for error checking. Additionally, the reported method can

tion 3.4), 3DFC passing rates are correlated with passing rates

continue to provide QA for older, more error-prone machines.

inferred from measurement-based QA. The correlation results could

Comparing to the previous treatment delivery log-based QA

be interpreted as a monotonic trend observed for the two obtained

methods, 3DFC QA is capable of presenting the QA results and the

passing rates, i.e., ﬂuence vs. dose, where higher ﬂuence errors indi-

computed beam ﬂuences in 3D geometry and therefore allows users

cates higher dose errors, and lower ﬂuence errors indicates lower

to easier interpret QA results in terms of the patient 3D anatomy

dose errors. Given the same error type and threshold, the 20 observa-

and the PTV target. In comparison to 2DFC (using composite ﬂuence

tions (i.e., passing rates) obtained for both QA methods can be consid-

maps and ignoring gantry rotation), 3DFC QA can detect important

ered as two ranked variables in the Spearman’s correlation, which is

treatment delivery errors, such as gantry angle errors, and is more

proven to be much stronger than Pearson’s linear relationship.

sensitive to MU, jaw position, and collimator rotation errors. For the

Even though the reported 3DFC method digitally reconstructs 3D

case of MLC errors, even though the 3D method is less sensitive

ﬂuence from the treatment plan and treatment delivery logs, 3D ﬂuence

than the 2D method, the sensitivity is sufﬁcient for the general

can be also reconstructed from measured 2D ﬂuence using 2D diode

VMAT delivery veriﬁcation purpose. In comparison to other methods

arrays mounted on the gantry and rotate together with the gantry by:

that only check beam parameters in delivery log ﬁles, e.g., FracIðr~Þ ¼ Dt

tionCheck (Mobius Medical System, Houston, TX, USA), 3DFC com-

X
k

Gk ðr~ðtÞÞ 

pares 3D ﬂuences derived from log ﬁles with those speciﬁed by the

SAD2
ðr~ ~
sk Þ

(8)

treatment plans, thus enabling detection of frequently occurring

where G is a frame of the measured ﬂuence map movie, Dt is the

treatment plan data transfer errors (incorrect plan version, incorrect

measurement repetition period. Beam MU is not in this equation be-

version of the individual beams.11

cause it is reﬂected by the intensity of measured beam ﬂuence. Gan-

The described 3DFC method is not designed to catch most

try angles must be simultaneously measured.

errors in treatment planning system, e.g., imperfect beam modeling.
Its primary application is instead to catch certain rare errors such as
the junctions of closed MLC leaf pairs left inside the beam ﬁeld

5 | CONCLUSION

deﬁned by the X and Y jaws in Pinnacle step-and-shoot IMRT
plans.11 Compared to measurement-based QA, the results of 3DFC

An efﬁcient method, 3DFC, has been developed to calculate 3D ﬂu-

QA are less independent because the beam parameters in the deliv-

ence volumes using the beam parameters from both DICOM plan

eries were measured by the treatment machines instead by indepen-

ﬁles and machine delivery log ﬁles for verifying both IMRT and

dent measurement device. The beam output and the beam proﬁle

VMAT treatment deliveries. This method is designed to work com-

are not directly measured, either. The accuracy of the beam parame-

plementarily to other QA procedures including dose recalculations

ters provided in the machine log ﬁles must be independently veriﬁed

and phantom-based measurements in order to provide a quick and

through routine machine QA in order to be considered reliable. In

easy measurement of beam delivery ﬁdelity and better visual presen-

fact, in one reported incident MLC positions recorded in the log ﬁle

tation of delivery errors in 3D. The reported method could be useful

were shown to be inconsistent with observed, true positions.37

in catching both treatment plan data transfer errors and treatment

Therefore, concerns and debates continue on the merits of log-ﬁle

delivery problems.

based QA.5 For these reasons, the reported 3DFC method is currently used as a complementary tool to measurement-based QA for
pre-treatment IMRT and VMAT patient-speciﬁc QA in our clinic.
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